MedPath

Albuterol Sulfate

Approved
Approval ID

9e6e982b-7dfe-45b8-aa76-754e8d2a8ef6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 1, 2022

Manufacturers
FDA

Mylan Pharmaceuticals Inc.

DUNS: 059295980

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Albuterol Sulfate

PRODUCT DETAILS

NDC Product Code0378-7057
Application NumberANDA214531
Marketing CategoryC73584
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateApril 15, 2022
Generic NameAlbuterol Sulfate

INGREDIENTS (4)

ALBUTEROL SULFATEActive
Quantity: 0.63 mg in 3 mL
Code: 021SEF3731
Classification: ACTIM
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT

Albuterol Sulfate

PRODUCT DETAILS

NDC Product Code0378-7058
Application NumberANDA214531
Marketing CategoryC73584
Route of AdministrationRESPIRATORY (INHALATION)
Effective DateApril 15, 2022
Generic NameAlbuterol Sulfate

INGREDIENTS (4)

ALBUTEROL SULFATEActive
Quantity: 1.25 mg in 3 mL
Code: 021SEF3731
Classification: ACTIM
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Albuterol Sulfate - FDA Drug Approval Details